Drugs / Stem Cells Lenses
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06952114 | May → Dec 2025 overdue | chronic graft versus host disease | Guangdong ProCapZoom Biosciences Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stem Cells Lenses | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06952114 ↗ |
| Action | Inhibit | “Using UCMSCs to locally modulate donor T cells and prevent them from attacking the ocular surface tissues of the recipient” NCT06952114 ↗ |
| Modality | Cell therapy | “administration of UCMSCs” NCT06952114 ↗ |
| Route | Other | “Each subject will wear Stem Cells Lenses for four consecutive days.” NCT06952114 ↗ |